TSS:Hg 78211.1

Basic information about the TSS

---

TSS ID: hg_78211.1 Species: human Chr: chr7		Start: 38178216 End: 38178280 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000009041.12 ENST00000434197.5 AK315404 Distance: 0 GeneID: 83930 HGNC/MGI_ID: HGNC:19169 UniProt_ID: A0A024RA89 C9JKL2 O95772

Gene_name: STARD3 N-terminal like Gene_symbol: STARD3NL Gene_synonyms: MENTHO MGC3251 Gene_source: HGNC:19169

TATA-Box annotation

---

Distance to TSS:	3
Nearest PromoterID:	NM_001363339
Entrez ID:	83930
Nearest Unigene:	Hs.309753
Nearest Refseq:	NM_032016
Nearest Ensembl:	ENSG00000010270
Gene Name:	STARD3 N-terminal like
Gene Alias:	MENTHO
Gene Description:	STARD3 N-terminal like
Gene Type:	protein-coding
CpG%:	0.105
GC%:	0.691542
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@STARD3NL p2@STARD3NL
Sample		p1@STARD3NL	p2@STARD3NL
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	8.96	12.47
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	11.33	8.09
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	8.87	10.22
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	4.78	8.32
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	8.77	10.12
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	8.72	6.01
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	16.34	10.24
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	11.38	8.72
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	12.18	10.90
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	10.43	5.22
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	4.45	7.68
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	7.32	6.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	29.50	10.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	23.00	8.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	22.61	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	22.63	6.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	21.62	7.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	20.25	7.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	23.99	6.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	35.05	9.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	27.53	6.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	26.07	8.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	28.31	7.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	27.91	5.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	31.22	6.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	20.89	8.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	18.13	6.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	30.88	10.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	26.01	9.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	30.40	8.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	27.01	7.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	28.13	9.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	21.74	7.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	18.97	5.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	29.54	8.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	28.74	10.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	30.04	13.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	23.37	6.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	29.71	8.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	21.61	8.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	24.23	7.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	20.06	9.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	33.95	13.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	30.94	13.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	29.92	13.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	26.29	12.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	35.75	13.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	24.14	16.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	35.67	11.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	32.15	11.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	29.51	17.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	37.80	16.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	29.81	8.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	26.51	10.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	30.20	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	19.75	12.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	40.51	5.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	38.22	13.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	32.69	8.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	45.83	9.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	35.33	7.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	22.29	3.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	27.86	7.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	80.26	8.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	46.86	8.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	86.87	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	40.95	7.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	33.22	11.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	41.28	7.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	47.36	16.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	48.88	12.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	49.22	13.76
Adipocyte - breast, donor1	11376-118A8	15.20	9.98
Adipocyte - breast, donor2	11327-117E4	8.18	4.97
Adipocyte - omental, donor1	11473-119C6	9.16	11.96
Adipocyte - omental, donor2	11474-119C7	13.45	21.68
Adipocyte - omental, donor3	11475-119C8	17.08	7.03
Adipocyte - perirenal, donor1	11476-119C9	22.97	10.21
Adipocyte - subcutaneous, donor1	11259-116F8	2.20	4.40
Adipocyte - subcutaneous, donor2	11336-117F4	14.00	5.87
Adipocyte - subcutaneous, donor3	11408-118E4	6.43	6.26
Adipocyte differentiation, day04, donor1	13019-139D4	18.58	11.54
Adipocyte differentiation, day04, donor2	13022-139D7	14.67	4.63
Adipocyte differentiation, day04, donor3	13025-139E1	13.38	8.08
Adipocyte differentiation, day04, donor4	13028-139E4	7.05	8.23
Adipocyte differentiation, day08, donor1	13020-139D5	11.58	8.04
Adipocyte differentiation, day08, donor2	13023-139D8	9.04	10.01
Adipocyte differentiation, day08, donor3	13026-139E2	7.46	4.80
Adipocyte differentiation, day08, donor4	13029-139E5	8.90	8.35
Adipocyte differentiation, day12, donor1	13021-139D6	9.15	9.98
Adipocyte differentiation, day12, donor2	13024-139D9	9.54	8.04
Adipocyte differentiation, day12, donor3	13027-139E3	6.54	8.18
Adipocyte differentiation, day12, donor4	13030-139E6	6.09	6.39
Alveolar Epithelial Cells, donor1	11510-119G7	32.49	13.70
Alveolar Epithelial Cells, donor2	11590-120G6	15.42	8.61
Alveolar Epithelial Cells, donor3	11671-122G6	8.39	7.19
Amniotic Epithelial Cells, donor1	11533-120A3	11.69	16.19
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	13.39
Amniotic Epithelial Cells, donor3	11694-123A2	13.15	13.15
Anulus Pulposus Cell, donor1	11248-116E6	22.20	6.18
Anulus Pulposus Cell, donor2	11463-119B5	22.53	8.08
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	17.07	10.78
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	20.40	13.89
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	10.70
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	17.94	10.76
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	15.18	7.59
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	12.54	9.24
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	15.59	9.75
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	22.33	14.08
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	17.22	3.56
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	22.22	8.66
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	19.59	12.34
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	13.79
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	21.25	11.20
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	9.55	9.55
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	17.34	9.50
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	15.54	10.72
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	13.98	9.82
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	15.24	7.75
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	13.66	5.85
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	15.26	7.30
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	12.01	15.61
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	7.08
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	19.04	10.81
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	18.93	9.22
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	19.35	9.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	8.48	8.48
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	16.53	10.83
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	17.10	10.05
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	16.26	7.23
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	22.05	10.79
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	17.69	10.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	9.27	10.70
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	12.28	9.36
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	17.76	9.33
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	21.38	7.13
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	14.24	4.07
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	18.59	9.17
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	11.44	5.08
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	14.67	8.20
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	22.86	8.26
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	14.21	8.12
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	21.73	9.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	18.82	13.39
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	9.27
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	14.79
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	16.72	13.51
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	10.23	6.62
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	13.12	6.56
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	19.31	8.97
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	25.50	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	18.30	14.24
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	16.10	14.24
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	13.46	7.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	15.77	11.95
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	18.63	12.64
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	1.53	6.10
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	20.49	14.95
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	16.15	11.12
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	15.99	9.09
Astrocyte - cerebellum, donor1	11500-119F6	33.28	9.95
Astrocyte - cerebellum, donor2	11580-120F5	29.95	10.95
Astrocyte - cerebellum, donor3	11661-122F5	15.73	7.76
Astrocyte - cerebral cortex, donor1	11235-116D2	63.44	6.27
Astrocyte - cerebral cortex, donor2	11316-117D2	44.65	5.82
Astrocyte - cerebral cortex, donor3	11392-118C6	49.97	9.84
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	23.40	27.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	24.56	31.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	21.96	24.47
Basophils, donor1	12241-129G9	6.28	20.92
Basophils, donor2	12242-129H1	3.25	20.57
Basophils, donor3	12243-129H2	6.61	19.70
Bronchial Epithelial Cell, donor1	11511-119G8	2.80	10.56
Bronchial Epithelial Cell, donor2	11591-120G7	3.66	6.40
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	21.52
Bronchial Epithelial Cell, donor4	11453-119A4	13.18	13.81
Bronchial Epithelial Cell, donor5	11457-119A8	15.80	12.48
Bronchial Epithelial Cell, donor6	11461-119B3	7.14	5.76
Bronchial Epithelial Cell, donor7	11769-123I5	3.24	7.38
Burkitt's lymphoma cell line:DAUDI	10422-106C8	13.19	21.64
Burkitt's lymphoma cell line:RAJI	10476-106I8	14.21	27.72
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	28.14	33.58
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	20.68
CD14+ Monocytes, donor1	11224-116B9	7.33	21.98
CD14+ Monocytes, donor2	11305-117B9	5.75	19.30
CD14+ Monocytes, donor3	11381-118B4	8.56	23.93
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	22.08	30.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	23.12	23.50
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	31.56	32.87
CD14+ monocytes - mock treated, donor1	11863-125A9	18.36	21.68
CD14+ monocytes - mock treated, donor2	11873-125C1	14.79	20.22
CD14+ monocytes - mock treated, donor3	11883-125D2	19.19	22.74
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	20.09	23.27
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	22.91	22.63
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	34.21	29.01
CD14+ monocytes - treated with BCG, donor1	11860-125A6	14.69	19.58
CD14+ monocytes - treated with BCG, donor2	11870-125B7	14.60	21.54
CD14+ monocytes - treated with BCG, donor3	11880-125C8	23.72	31.12
CD14+ monocytes - treated with Candida, donor1	11868-125B5	20.37	26.22
CD14+ monocytes - treated with Candida, donor2	11878-125C6	25.87	31.15
CD14+ monocytes - treated with Candida, donor3	11888-125D7	39.94	23.30
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	22.46	19.19
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	18.16	24.54
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	45.80	29.98
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	33.86	30.66
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	25.56	23.07
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	32.30	30.12
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	8.34	20.71
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	15.70	23.38
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	12.62	25.25
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	36.56	40.23
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	30.29	59.53
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	49.14	62.30
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	11.68	23.02
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	10.41	23.42
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	20.91	27.59
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	36.03	37.26
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	26.66	35.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	49.65	56.37
CD14+CD16+ Monocytes, donor1	11789-124B7	8.50	29.86
CD14+CD16+ Monocytes, donor2	11801-124D1	8.32	26.33
CD14+CD16+ Monocytes, donor3	11912-125G4	8.66	33.58
CD14+CD16- Monocytes, donor1	11788-124B6	14.33	30.83
CD14+CD16- Monocytes, donor2	11799-124C8	9.43	28.29
CD14+CD16- Monocytes, donor3	11910-125G2	8.70	28.32
CD14-CD16+ Monocytes, donor1	11790-124B8	8.68	40.57
CD14-CD16+ Monocytes, donor2	11800-124C9	4.83	32.50
CD14-CD16+ Monocytes, donor3	11911-125G3	5.26	35.16
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	2.03	28.45
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	6.10	25.09
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	13.46	31.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	12.79	26.65
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	5.36	26.80
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	7.72	25.97
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	3.14	21.18
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	10.55	39.55
CD19+ B Cells, donor1	11544-120B5	3.29	22.19
CD19+ B Cells, donor2	11624-122B4	5.80	18.14
CD19+ B Cells, donor3	11705-123B4	6.06	15.65
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	12.12	15.35
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	7.59	16.78
CD34+ Progenitors, donor1	11545-120B6	11.04	32.13
CD34+ Progenitors, donor2	11625-122B5	10.11	21.35
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	28.93	33.82
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	24.13	30.44
CD4+ T Cells, donor1	11225-116C1	0.71	22.14
CD4+ T Cells, donor2	11306-117C1	1.84	15.92
CD4+ T Cells, donor3	11382-118B5	1.52	24.40
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	1.79	14.55
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	0.90	14.60
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	1.15	16.39
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	2.37	25.60
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.00	27.39
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	2.17	18.21
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	2.03	17.12
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	2.26	16.77
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	2.69	25.10
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	2.80	20.96
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	2.64	21.12
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	1.69	12.23
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	2.70	19.53
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	1.34	16.37
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	1.09	21.48
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	0.00	21.97
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	3.59	32.28
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	3.52	23.73
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	3.25	17.98
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	4.41	29.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	2.02	19.21
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	3.03	26.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	2.61	21.79
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	4.45	29.20
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	2.77	38.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	2.79	37.69
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	3.05	41.82
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	4.17	42.45
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	0.00	15.40
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	3.94	31.87
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	2.77	42.93
CD8+ T Cells, donor1	11226-116C2	3.60	23.90
CD8+ T Cells, donor2	11307-117C2	1.13	19.52
CD8+ T Cells, donor3	11383-118B6	1.51	19.19
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	7.11	10.09
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	5.03	10.06
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	5.20	10.40
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	4.20	8.71
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	5.04	9.12
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	3.87	9.78
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	7.17	10.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	8.95	10.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	8.68	14.77
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	9.96	11.77
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	6.97	16.56
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	9.86	16.25
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	8.32	10.51
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	7.74	11.39
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	11.19	11.19
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	4.32	12.61
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	5.75	12.66
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	4.48	7.78
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	11.41	8.56
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	10.15	8.61
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	6.73	10.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	7.27	12.24
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	8.28	12.61
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	8.32	15.13
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	9.64	16.86
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	7.69	30.08
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	13.02	21.04
Cardiac Myocyte, donor1	11525-119I4	10.97	0.00
Cardiac Myocyte, donor2	11605-120I3	21.74	2.47
Cardiac Myocyte, donor3	11686-122I3	21.47	5.68
Chondrocyte - de diff, donor1	11261-116G1	28.08	17.33
Chondrocyte - de diff, donor2	11338-117F6	13.50	7.11
Chondrocyte - de diff, donor3	11410-118E6	17.41	10.58
Chondrocyte - re diff, donor2	11339-117F7	29.54	17.01
Chondrocyte - re diff, donor3	11411-118E7	12.13	10.11
Ciliary Epithelial Cells, donor1	11242-116D9	30.87	13.66
Ciliary Epithelial Cells, donor2	11323-117D9	31.85	10.47
Ciliary Epithelial Cells, donor3	11399-118D4	26.46	11.50
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	17.33	24.94
Corneal Epithelial Cells, donor1	11526-119I5	4.39	11.86
Corneal Epithelial Cells, donor2	11606-120I4	0.00	9.10
Corneal Epithelial Cells, donor3	11687-122I4	5.37	14.57
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	10.24	13.54
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	10.41	13.88
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	31.06
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	7.13	17.93
Dendritic Cells - plasmacytoid, donor1	11228-116C4	3.76	27.33
Dendritic Cells - plasmacytoid, donor2	11309-117C4	1.96	32.64
Dendritic Cells - plasmacytoid, donor3	11385-118B8	3.87	48.39
Endothelial Cells - Aortic, donor0	11207-116A1	34.35	6.84
Endothelial Cells - Aortic, donor1	11263-116G3	31.10	3.52
Endothelial Cells - Aortic, donor2	11340-117F8	21.49	9.33
Endothelial Cells - Aortic, donor3	11412-118E8	25.16	6.68
Endothelial Cells - Artery, donor1	11264-116G4	17.16	3.49
Endothelial Cells - Artery, donor2	11341-117F9	17.88	2.82
Endothelial Cells - Artery, donor3	11413-118E9	31.56	4.21
Endothelial Cells - Lymphatic, donor1	11236-116D3	24.83	9.09
Endothelial Cells - Lymphatic, donor2	11317-117D3	37.42	10.04
Endothelial Cells - Lymphatic, donor3	11393-118C7	25.65	16.07
Endothelial Cells - Microvascular, donor1	11265-116G5	29.42	5.05
Endothelial Cells - Microvascular, donor2	11342-117G1	21.35	11.45
Endothelial Cells - Microvascular, donor3	11414-118F1	21.13	3.83
Endothelial Cells - Thoracic, donor1	11266-116G6	45.21	14.80
Endothelial Cells - Thoracic, donor2	11343-117G2	25.16	2.62
Endothelial Cells - Umbilical vein, donor1	11243-116E1	55.29	14.04
Endothelial Cells - Umbilical vein, donor2	11324-117E1	30.20	9.34
Endothelial Cells - Umbilical vein, donor3	11400-118D5	37.25	7.33
Endothelial Cells - Vein, donor1	11267-116G7	29.58	9.10
Endothelial Cells - Vein, donor2	11344-117G3	14.67	4.89
Endothelial Cells - Vein, donor3	11416-118F3	38.00	5.65
Eosinophils, donor1	12244-129H3	0.00	91.48
Eosinophils, donor2	12245-129H4	9.90	31.35
Eosinophils, donor3	12246-129H5	10.70	39.24
Esophageal Epithelial Cells, donor1	11507-119G4	6.84	6.11
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	6.24
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	18.88	10.67
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	18.28	6.90
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	24.81	6.50
Fibroblast - Aortic Adventitial, donor1	11245-116E3	27.41	7.64
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	18.97	6.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	15.50	8.23
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	19.76	4.74
Fibroblast - Aortic Adventitial, donor3	11401-118D6	33.22	7.31
Fibroblast - Cardiac, donor1	11268-116G8	17.24	7.71
Fibroblast - Cardiac, donor2	11345-117G4	9.10	7.58
Fibroblast - Cardiac, donor3	11417-118F4	16.09	5.20
Fibroblast - Cardiac, donor4	11452-119A3	21.52	8.79
Fibroblast - Cardiac, donor5	11456-119A7	35.66	7.87
Fibroblast - Cardiac, donor6	11460-119B2	32.44	7.58
Fibroblast - Choroid Plexus, donor1	11492-119E7	25.86	12.06
Fibroblast - Choroid Plexus, donor2	11572-120E6	13.37	6.47
Fibroblast - Choroid Plexus, donor3	11653-122E6	13.18	7.32
Fibroblast - Conjunctival, donor1	11531-120A1	18.68	7.61
Fibroblast - Conjunctival, donor3	11692-122I9	25.27	7.12
Fibroblast - Dermal, donor1	11269-116G9	14.09	6.81
Fibroblast - Dermal, donor2	11346-117G5	13.21	8.02
Fibroblast - Dermal, donor3	11418-118F5	20.43	9.31
Fibroblast - Dermal, donor4	11450-119A1	25.66	10.17
Fibroblast - Dermal, donor5	11454-119A5	25.82	13.96
Fibroblast - Dermal, donor6	11458-119A9	27.61	17.22
Fibroblast - Gingival, donor1	11237-116D4	25.82	7.08
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	16.77	6.29
Fibroblast - Gingival, donor2	11318-117D4	37.82	5.53
Fibroblast - Gingival, donor3	11394-118C8	22.72	5.22
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	12.47	7.27
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	15.68	8.99
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	24.94	7.64
Fibroblast - Gingival, donor6 (control)	11922-125H5	18.12	7.03
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	4.59	6.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	19.60	12.14
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	20.18	10.36
Fibroblast - Gingival, donor8 (control)	11926-125H9	25.89	8.67
Fibroblast - Gingival, donor9 (control)	11927-125I1	12.91	9.98
Fibroblast - Lung, donor1	11270-116H1	16.31	9.52
Fibroblast - Lung, donor2	11347-117G6	20.89	4.48
Fibroblast - Lung, donor3	11419-118F6	16.88	4.43
Fibroblast - Lymphatic, donor1	11506-119G3	23.32	18.33
Fibroblast - Lymphatic, donor2	11586-120G2	11.19	12.59
Fibroblast - Lymphatic, donor3	11667-122G2	8.12	4.20
Fibroblast - Mammary, donor1	11540-120B1	21.92	19.49
Fibroblast - Mammary, donor2	11620-122A9	7.99	19.97
Fibroblast - Mammary, donor3	11701-123A9	23.83	17.87
Fibroblast - Periodontal Ligament, donor1	11238-116D5	35.50	8.34
Fibroblast - Periodontal Ligament, donor2	11319-117D5	32.76	8.80
Fibroblast - Periodontal Ligament, donor3	11395-118C9	27.54	10.71
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	12.21	14.12
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	21.87	12.69
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	26.79	13.11
Fibroblast - Pulmonary Artery, donor1	11250-116E8	32.72	7.96
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	31.70	15.44
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	14.03	4.68
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	14.63	7.91
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	6.55	4.56
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	8.53	10.30
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	11.43	11.83
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	13.54	6.32
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	17.49	11.55
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	4.81	5.06
Fibroblast - skin normal, donor1	11553-120C5	9.68	8.70
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	16.44	6.82
Fibroblast - skin normal, donor2	11561-120D4	21.80	11.45
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	8.16	6.65
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	10.52	12.76
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	30.94	20.69
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	11.17	9.85
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	23.22	10.87
Fibroblast - skin walker warburg, donor1	11554-120C6	25.64	12.31
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	11.13	6.12
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	88.64	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	0.87	9.59
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	9.19	11.61
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	12.23	11.97
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	13.03	15.59
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	14.55	6.12
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	31.90	4.47
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	46.50	13.69
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	51.84	9.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	39.27	8.90
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	40.81	11.29
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	44.41	8.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	48.60	8.15
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	30.51	7.96
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	20.35	5.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	24.26	7.02
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	18.00	6.45
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	37.79	8.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	31.98	6.09
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	19.31	2.85
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	34.91	8.90
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	30.39	6.73
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	20.76	6.78
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	23.34	7.98
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	29.25	9.54
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	19.66	7.82
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	29.84	6.86
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	32.06	8.48
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	38.66	7.80
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	31.22	7.91
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	26.81	6.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	32.09	7.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	36.27	7.74
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	27.97	7.76
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	28.88	7.84
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	26.06	8.99
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	30.35	4.84
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	24.47	9.70
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	33.21	10.82
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	28.20	8.75
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	26.94	12.51
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	28.14	8.91
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	23.88	7.12
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	27.37	7.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	35.23	8.57
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	24.59	9.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	25.81	7.29
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	27.96	11.57
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	29.95	6.95
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	23.41	9.18
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	27.46	9.20
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	27.11	8.13
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	19.36	8.85
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	23.25	6.80
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	24.79	8.93
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	19.39	8.31
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	16.95	9.48
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	19.06	21.10
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	27.47	10.15
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	19.11	5.85
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	20.87	6.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	28.79	8.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	31.08	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	21.68	4.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	42.07	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	25.92	6.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	32.09	9.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	29.56	5.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	27.01	9.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	28.41	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	13.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	28.52	5.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	26.80	3.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	31.04	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	29.26	7.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	26.49	3.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	41.76	6.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	28.63	6.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	21.90	4.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	49.13	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	33.55	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	28.77	5.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	42.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	34.60	5.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	41.40	2.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	66.22	8.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	38.91	5.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	35.26	4.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	29.82	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	43.88	6.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	25.95	9.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	46.80	9.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	46.66	5.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	31.08	8.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	37.77	8.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	32.67	8.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	36.43	7.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	26.28	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	30.44	7.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	37.36	7.76
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	14.84	4.57
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	8.32	7.07
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	12.37	9.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	5.07	8.25
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	5.85	11.70
Hep-2 cells mock treated, biol_rep1	11898-125E8	14.62	9.63
Hep-2 cells mock treated, biol_rep2	11899-125E9	10.13	7.76
Hep-2 cells mock treated, biol_rep3	11900-125F1	10.69	10.92
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	16.29	8.85
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	9.89	9.67
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	10.33	9.47
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	12.58	8.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	10.98	5.66
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	6.73	6.73
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	43.65	9.51
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	22.51	4.76
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	2.64	7.93
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	24.34	6.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	13.80	4.36
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	18.36	5.25
Hepatocyte, donor1	11523-119I2	1.21	4.84
Hepatocyte, donor2	11603-120I1	7.54	3.23
Hepatocyte, donor3	11684-122I1	4.29	8.59
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	3.92	43.08
Intestinal epithelial cells (polarized), donor1	11246-116E4	19.75	12.06
Iris Pigment Epithelial Cells, donor1	11530-119I9	18.52	9.47
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	9.55	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	4.15	5.54
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	23.74
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	9.75	6.50
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	9.26	3.97
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	3.33	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	11.34	7.56
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	6.19	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	8.40	7.75
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	4.83	6.44
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	4.07	4.89
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	6.30	2.52
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	7.23	3.21
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	6.46	6.46
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	13.22	5.19
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	9.07	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	6.46	5.38
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	1.27	7.62
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	7.65	2.55
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	5.47	5.47
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	10.71	3.57
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	8.03	4.01
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	3.51	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	6.95	4.17
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4.43	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	9.73
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	8.72	6.98
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	9.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	9.60	3.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	5.52	4.60
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	12.69	5.29
Keratinocyte - epidermal, donor1	11272-116H3	4.65	5.96
Keratinocyte - epidermal, donor2	11349-117G8	1.17	5.27
Keratinocyte - epidermal, donor3	11421-118F8	10.89	11.93
Keratinocyte - oral, donor1	11251-116E9	11.69	18.73
Keratocytes, donor1	11527-119I6	18.22	4.13
Keratocytes, donor2	11607-120I5	23.44	7.03
Keratocytes, donor3	11688-122I5	10.28	4.74
Krukenberg tumor cell line:HSKTC	10687-109F3	8.79	43.96
Lens Epithelial Cells, donor1	11529-119I8	12.94	9.71
Lens Epithelial Cells, donor2	11609-120I7	29.06	14.65
Lens Epithelial Cells, donor3	11690-122I7	26.74	15.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	24.78	11.86
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	14.51	5.58
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	32.90	11.02
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	14.52	8.07
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	16.07	9.77
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	21.02	7.87
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	16.42	9.03
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	14.41	9.86
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	19.28	8.30
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	19.78	11.47
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	18.81	7.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	18.51	5.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	18.81	8.36
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	14.79	7.87
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	21.98	7.42
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	25.25	10.16
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	12.78	7.17
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	21.78	7.87
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	17.44	9.87
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	9.66	3.51
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	12.94	6.47
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	19.40	6.79
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	19.93	6.46
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	24.22	9.99
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	14.00	6.74
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	21.15	9.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	21.80	7.97
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	15.13	10.32
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	15.62	7.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	18.77	9.01
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	15.02	5.81
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	8.60	7.94
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	19.20	8.42
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	21.10	7.40
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	18.53	8.89
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	18.29	7.01
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	20.91	5.79
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	20.09	10.65
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	26.45	9.66
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	29.16	8.89
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	18.42	5.33
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	14.32	5.14
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	23.28	11.46
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	14.05	7.51
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	11.30	3.06
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	29.58	9.28
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	10.76	4.61
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	17.01	6.56
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	2.27	6.80
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	0.77	7.67
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	1.48	10.39
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	0.85	9.31
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	0.00	14.07
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	1.87	6.54
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	1.03	8.24
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	1.19	9.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	1.81	9.73
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	0.58	6.69
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	2.70	10.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	2.03	8.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	2.05	7.19
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	1.41	14.47
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	1.33	11.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	2.55	9.17
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	1.33	10.94
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	2.46	9.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	1.84	11.04
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	2.45	14.68
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	2.50	9.37
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	2.52	13.45
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	0.00	9.27
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	1.74	10.16
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	1.49	12.85
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	2.21	9.41
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	1.06	5.66
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	1.48	9.22
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	1.15	11.51
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	2.30	8.06
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	2.26	7.36
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	1.64	8.20
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	0.45	7.23
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	0.72	7.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	2.24	11.95
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	2.60	10.03
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	2.15	8.18
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	0.86	9.42
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	0.33	8.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	4.22	10.26
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	0.71	10.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	2.75	8.59
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	3.22	9.66
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	0.67	9.43
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	1.85	8.15
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	1.16	10.47
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	1.06	6.35
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	2.80	8.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	0.73	10.90
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	1.53	7.67
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	2.47	7.89
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	0.00	9.41
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	3.02	10.06
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	1.80	8.56
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	0.00	5.16
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	1.34	11.58
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	1.96	8.99
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	2.64	4.62
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	3.63	12.97
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	0.88	10.50
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	0.56	11.18
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	0.88	9.72
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	1.54	10.80
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	1.52	6.58
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	0.96	10.09
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	1.59	9.54
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	1.82	8.51
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	1.38	6.23
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	1.14	12.54
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	1.55	8.26
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	1.81	7.86
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	1.27	7.61
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	2.13	8.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	1.15	9.77
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	2.57	9.26
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	1.41	5.66
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	2.84	11.35
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	2.08	12.48
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	0.78	14.09
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	2.92	11.27
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	1.86	13.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	1.34	10.70
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	2.14	9.62
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	1.21	9.29
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	1.84	9.18
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	0.89	10.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	0.57	14.82
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	4.60	12.27
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	1.64	13.13
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	1.78	11.14
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	3.12	11.96
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	2.65	10.61
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	4.16	12.47
Macrophage - monocyte derived, donor1	11232-116C8	22.56	36.69
Macrophage - monocyte derived, donor2	11313-117C8	20.92	21.47
Macrophage - monocyte derived, donor3	11389-118C3	34.21	21.50
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	21.77	14.34
Mallassez-derived cells, donor2	11929-125I3	16.16	9.98
Mallassez-derived cells, donor3	11930-125I4	17.79	11.40
Mammary Epithelial Cell, donor1	11273-116H4	16.04	7.07
Mammary Epithelial Cell, donor2	11350-117G9	17.95	6.95
Mammary Epithelial Cell, donor3	11422-118F9	7.73	4.74
Mast cell - stimulated, donor1	11487-119E2	41.35	18.98
Mast cell, donor1	11563-120D6	15.36	19.47
Mast cell, donor2	11565-120D8	12.48	10.10
Mast cell, donor3	11566-120D9	18.69	15.08
Mast cell, donor4	11567-120E1	10.28	10.11
Mast cell, expanded and stimulated, donor5	11940-126A5	15.53	23.29
Mast cell, expanded and stimulated, donor8	11942-126A7	15.18	9.92
Mast cell, expanded, donor5	11939-126A4	21.34	21.34
Mast cell, expanded, donor8	11941-126A6	10.38	12.05
Melanocyte - dark, donor1	11502-119F8	44.87	6.57
Melanocyte - dark, donor2	11582-120F7	21.11	3.11
Melanocyte - dark, donor3	11663-122F7	41.15	15.86
Melanocyte - light, donor1	11274-116H5	15.75	4.23
Melanocyte - light, donor2	11351-117H1	17.74	6.82
Melanocyte - light, donor3	11423-118G1	9.54	3.47
Melanocyte, donor1 (MC+1)	12641-134G4	36.03	9.48
Melanocyte, donor2 (MC+2)	12739-135I3	28.78	5.65
Melanocyte, donor3 (MC+3)	12837-137B2	29.46	4.55
Meningeal Cells, donor1	11493-119E8	40.82	13.65
Meningeal Cells, donor2	11573-120E7	59.42	13.20
Meningeal Cells, donor3	11654-122E7	34.23	9.13
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	43.91	10.84
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	21.33	12.28
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	5.26
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	5.23	5.23
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	16.50	8.61
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	20.33	9.95
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	24.63	10.05
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	29.01	9.67
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	27.03	8.77
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	20.87	11.25
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	46.68	18.70
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	4.46	6.69
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	16.84	8.16
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	4.45	8.01
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	18.57	9.61
Mesenchymal stem cells - adipose, donor0	11217-116B2	29.06	11.34
Mesenchymal stem cells - hepatic, donor0	11218-116B3	17.83	11.26
Mesenchymal stem cells - umbilical, donor0	11214-116A8	20.32	9.43
Mesothelial Cells, donor1	11247-116E5	47.20	7.96
Mesothelial Cells, donor2	12156-128G5	32.53	7.51
Mesothelial Cells, donor3	11402-118D7	26.45	9.18
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	10.80	22.96
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	21.67	27.09
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	17.96	23.85
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	38.03
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	16.43	23.56
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	13.28	18.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	34.74
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	18.02	28.53
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	15.36	24.67
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	38.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	19.92	23.78
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	17.03	22.57
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	17.10
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.96	15.93
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	20.14	20.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	6.58	19.74
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	17.19	20.16
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	5.52	11.97
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	14.31	23.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	25.15
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	17.31	22.33
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	14.02	14.74
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	13.82	17.14
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	17.50	19.34
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	16.83	20.40
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	25.27	15.29
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	17.81	21.88
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	20.23	16.23
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	20.64
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	21.68	18.18
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	12.67	18.76
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	16.57	24.85
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	19.03	16.31
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	11.47	17.35
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	10.90
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	21.14	12.01
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	14.41	20.41
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	13.71	12.34
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	22.03	21.52
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	8.15
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	22.77	16.64
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	13.24	23.18
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	14.73	14.09
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	22.06	20.83
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.05	25.05
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	17.68
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	21.54	13.33
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	12.69	11.82
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	15.27	13.85
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	27.21	17.67
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	18.70	15.38
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	15.73	12.24
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	19.00	18.10
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	19.20	16.70
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	19.39	14.78
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	11.95	14.23
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	21.69	16.03
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	22.29	16.33
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	18.87	18.87
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	18.42	4.45
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	13.88	18.68
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	26.04	26.94
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	18.08	14.41
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	20.07	15.93
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	24.55	20.79
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	17.06	15.55
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	22.73	17.61
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	24.33	19.42
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	14.34	14.99
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	16.17	18.23
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	32.58	19.03
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	15.66	11.95
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	16.38	19.06
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	26.37
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	32.08	23.17
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	28.91	18.73
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	17.88	21.04
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	21.35	25.11
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	19.56	27.94
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	29.29	32.30
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	20.51	18.91
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	25.11	16.63
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	25.05	14.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	28.58	18.32
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	24.89	7.78
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	32.07	31.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	30.91	34.78
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	25.25	21.21
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	30.36	31.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	43.58	24.51
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	37.51	24.80
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	36.44	29.15
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	45.31	13.59
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	28.55
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	52.20	13.05
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	19.01
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	37.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	25.85	12.71
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	10.97	9.41
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	26.03	10.01
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	20.87	11.69
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	36.70	12.93
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	23.94	9.58
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	18.36	10.20
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	5.51	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	17.58	4.19
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	24.64	12.78
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	36.75	6.76
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	13.03	6.10
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	15.39	3.97
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	16.78	5.14
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	24.48	6.12
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	27.43	8.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	14.03	5.65
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	15.38	9.02
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	17.41	7.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	7.88	4.59
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	18.38	9.11
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	15.17	10.41
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	18.28	9.85
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	13.79	12.87
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	26.35	9.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	12.76	5.52
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	2.53	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	12.25	5.35
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	22.02	11.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	16.85	9.97
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	27.90	11.59
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	31.99	15.99
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	7.21	4.06
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	14.28	7.94
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	28.79	12.07
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	17.41	10.97
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	22.49	18.90
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	20.48	11.33
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	10.40	6.78
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	29.98	7.06
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	15.96	7.31
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	28.27	17.86
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	13.02	14.93
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	22.68	18.75
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	10.61	7.29
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	12.88	9.49
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	22.56	13.41
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	17.31	16.05
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	20.58	16.95
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	22.15	4.75
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	11.34	3.40
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	5.06
Myoblast, donor1	11241-116D8	16.90	8.20
Myoblast, donor2	11322-117D8	19.56	6.90
Myoblast, donor3	11398-118D3	23.71	9.92
NK T cell leukemia cell line:KHYG-1	10777-110G3	12.84	29.62
Natural Killer Cells, donor1	11230-116C6	2.15	17.53
Natural Killer Cells, donor2	11311-117C6	3.32	25.03
Natural Killer Cells, donor3	11387-118C1	3.68	16.56
Neural stem cells, donor1	11275-116H6	60.61	17.42
Neural stem cells, donor2	11352-117H2	36.59	42.36
Neurons, donor1	11494-119E9	36.41	53.48
Neurons, donor2	11574-120E8	36.99	41.39
Neurons, donor3	11655-122E8	44.40	36.18
Neutrophils, donor1	11233-116C9	19.49	43.62
Neutrophils, donor2	11314-117C9	14.49	40.58
Neutrophils, donor3	11390-118C4	8.55	26.88
Nucleus Pulposus Cell, donor1	11252-116F1	25.29	8.55
Nucleus Pulposus Cell, donor2	11409-118E5	15.30	7.49
Nucleus Pulposus Cell, donor3	11462-119B4	25.07	10.43
Olfactory epithelial cells, donor1	11933-125I7	15.55	8.12
Olfactory epithelial cells, donor2	11934-125I8	19.83	4.34
Olfactory epithelial cells, donor3	11935-125I9	13.51	5.90
Olfactory epithelial cells, donor4	11936-126A1	16.07	6.72
Oligodendrocyte - precursors, donor1	11496-119F2	30.09	10.83
Osteoblast - differentiated, donor1	11276-116H7	5.74	10.21
Osteoblast - differentiated, donor2	11353-117H3	6.86	12.57
Osteoblast - differentiated, donor3	11425-118G3	16.14	6.21
Osteoblast, donor1	11277-116H8	14.66	8.40
Osteoblast, donor2	11354-117H4	30.20	15.45
Osteoblast, donor3	11426-118G4	27.19	10.13
Pancreatic stromal cells, donor1	11249-116E7	21.65	8.59
Pericytes, donor1	11491-119E6	10.24	13.02
Pericytes, donor2	11571-120E5	14.49	11.54
Pericytes, donor3	11652-122E5	20.96	10.17
Perineurial Cells, donor1	11499-119F5	16.50	13.22
Perineurial Cells, donor2	11579-120F4	28.25	4.32
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	6.69	25.82
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	4.41	15.67
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	6.47	20.71
Placental Epithelial Cells, donor1	11278-116H9	6.70	5.74
Placental Epithelial Cells, donor2	11355-117H5	3.33	5.54
Placental Epithelial Cells, donor3	11427-118G5	3.93	9.23
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	12.03	6.65
Preadipocyte - breast, donor1	11467-119B9	9.75	10.32
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	7.05	3.92
Preadipocyte - breast, donor2	11328-117E5	9.68	11.48
Preadipocyte - omental, donor1	11468-119C1	10.98	10.12
Preadipocyte - omental, donor2	11329-117E6	11.35	9.60
Preadipocyte - omental, donor3	11403-118D8	17.62	11.32
Preadipocyte - perirenal, donor1	11469-119C2	9.84	8.86
Preadipocyte - subcutaneous, donor1	11279-116I1	19.35	8.29
Preadipocyte - subcutaneous, donor2	11356-117H6	28.16	8.50
Preadipocyte - subcutaneous, donor3	11428-118G6	30.82	8.34
Preadipocyte - visceral, donor1	11280-116I2	28.04	7.82
Preadipocyte - visceral, donor2	11357-117H7	22.55	7.82
Preadipocyte - visceral, donor3	11429-118G7	22.78	7.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	20.82	6.49
Prostate Epithelial Cells, donor2	11331-117E8	12.19	8.12
Prostate Epithelial Cells, donor3	11404-118D9	5.02	5.33
Prostate Stromal Cells, donor1	11254-116F3	26.77	7.97
Prostate Stromal Cells, donor2	11332-117E9	22.95	8.25
Prostate Stromal Cells, donor3	11405-118E1	24.30	9.07
Renal Cortical Epithelial Cells, donor1	11516-119H4	14.96	11.31
Renal Cortical Epithelial Cells, donor2	11596-120H3	28.28	10.19
Renal Epithelial Cells, donor1	11517-119H5	11.67	4.57
Renal Epithelial Cells, donor2	11597-120H4	21.34	7.11
Renal Epithelial Cells, donor3	11678-122H4	29.22	8.26
Renal Glomerular Endothelial Cells, donor1	11514-119H2	21.11	10.89
Renal Glomerular Endothelial Cells, donor2	11594-120H1	34.77	12.80
Renal Glomerular Endothelial Cells, donor3	11675-122H1	24.42	10.88
Renal Glomerular Endothelial Cells, donor4	11783-124B1	9.98	8.65
Renal Mesangial Cells, donor1	11518-119H6	27.95	5.94
Renal Mesangial Cells, donor2	11598-120H5	33.86	13.79
Renal Mesangial Cells, donor3	11679-122H5	9.99	5.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	34.09	16.11
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	13.92	9.70
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	27.38	9.26
Retinal Pigment Epithelial Cells, donor0	11215-116A9	39.93	11.93
Retinal Pigment Epithelial Cells, donor1	11528-119I7	18.19	11.65
Retinal Pigment Epithelial Cells, donor2	11608-120I6	14.41	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	10.54	7.78
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	19.51	13.50
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	19.65	3.57
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	20.36	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	16.24	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	22.36	5.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	23.04	3.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	32.57	6.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	32.50	6.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	27.39	4.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	26.12	5.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	20.26	4.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	24.35	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	29.39	5.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	25.82	3.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	22.97	3.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	27.22	3.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	18.35	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	22.64	3.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	23.86	5.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	21.90	5.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	25.89	4.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	29.22	4.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	21.47	7.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	16.82	2.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	21.70	4.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	21.15	3.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	22.56	3.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	27.80	4.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	19.11	5.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	23.02	6.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	22.68	7.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	20.32	5.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	19.25	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	18.38	5.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	19.92	7.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	24.69	4.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	27.96	6.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	24.24	4.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	20.44	4.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	22.98	6.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	24.03	3.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	27.82	4.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	19.99	3.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	21.02	6.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	26.91	5.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	25.19	2.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	26.56	4.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	21.66	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	15.72	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	24.11	3.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	31.29	4.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	30.42	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	25.32	6.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	24.20	4.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	20.97	6.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	25.74	4.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	24.55	4.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	28.85	3.61
Schwann Cells, donor1	11498-119F4	18.81	8.84
Schwann Cells, donor2	11578-120F3	6.80	10.21
Schwann Cells, donor3	11659-122F3	21.25	11.17
Sebocyte, donor1	11220-116B5	13.15	12.60
Sebocyte, donor2	11301-117B5	7.35	7.81
Sebocyte, donor3	11378-118B1	12.16	7.21
Sertoli Cells, donor1	11255-116F4	19.88	4.97
Sertoli Cells, donor2	11333-117F1	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	14.16	4.13
Skeletal Muscle Cells, donor2	11358-117H8	10.12	1.45
Skeletal Muscle Cells, donor3	11430-118G8	11.70	9.20
Skeletal Muscle Cells, donor4	11451-119A2	21.21	11.31
Skeletal Muscle Cells, donor5	11455-119A6	18.73	10.11
Skeletal Muscle Cells, donor6	11459-119B1	32.78	12.47
Skeletal Muscle Satellite Cells, donor1	11240-116D7	31.25	7.69
Skeletal Muscle Satellite Cells, donor2	11321-117D7	21.55	5.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	32.94	8.83
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	22.16	6.66
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	13.03	6.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	24.36	5.37
Skin - palm, donor1	10286-104F7	5.37	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	11.96	9.23
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	10.63	17.18
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	12.72	9.61
Small Airway Epithelial Cells, donor1	11256-116F5	13.34	10.98
Small Airway Epithelial Cells, donor2	11334-117F2	11.82	6.19
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	21.99	17.13
Small Airway Epithelial Cells, donor3	11406-118E2	8.17	7.94
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	16.66	6.79
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	14.45	4.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	23.51	8.23
Smooth Muscle Cells - Aortic, donor1	11283-116I5	20.11	3.76
Smooth Muscle Cells - Aortic, donor2	11360-117I1	18.51	7.09
Smooth Muscle Cells - Aortic, donor3	11432-118H1	18.54	8.50
Smooth Muscle Cells - Bladder, donor1	11519-119H7	8.01	7.01
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	18.23	8.92
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	24.16	14.63
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	42.38	22.41
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	26.70	8.14
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	29.83	13.58
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	34.74	10.68
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	22.77	9.11
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	11.26	7.31
Smooth Muscle Cells - Carotid, donor1	11285-116I7	16.42	10.61
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	12.24
Smooth Muscle Cells - Carotid, donor3	11434-118H3	21.46	8.58
Smooth Muscle Cells - Colonic, donor1	11239-116D6	24.92	5.90
Smooth Muscle Cells - Colonic, donor2	11320-117D6	22.82	5.38
Smooth Muscle Cells - Colonic, donor3	11396-118D1	28.34	7.14
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	17.94	7.12
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	31.26	4.31
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	34.97	8.37
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	15.70	6.49
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	23.01	5.81
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	18.52	10.97
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	33.22	6.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	21.13	6.64
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	33.38	11.66
Smooth Muscle Cells - Prostate, donor1	11257-116F6	27.56	10.25
Smooth Muscle Cells - Prostate, donor2	11335-117F3	17.78	5.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	19.53	8.88
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	25.63	11.46
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	15.75	8.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	11.63	20.68
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	15.81	14.88
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	17.17	12.12
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	29.15	10.03
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	15.34	6.19
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	25.91	8.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	16.82	3.74
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	16.98	10.79
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	27.03	11.47
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	32.91	9.97
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	30.18	11.46
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	24.38	11.31
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	5.24	10.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	26.67	9.54
Smooth Muscle Cells - Uterine, donor1	11258-116F7	26.29	13.26
Smooth Muscle Cells - Uterine, donor3	11466-119B8	27.21	7.61
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	8.75	8.55
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	14.81	9.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	20.83	3.35
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	24.08	10.06
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	17.89	5.11
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	17.72	7.88
Smooth muscle cells - airway, control, donor1	11966-126D4	16.00	7.11
Smooth muscle cells - airway, control, donor2	11967-126D5	19.97	11.18
Smooth muscle cells - airway, control, donor3	11968-126D6	12.54	7.94
Smooth muscle cells - airway, control, donor4	11969-126D7	13.29	6.42
Synoviocyte, donor1	11291-117A4	17.17	8.42
Synoviocyte, donor2	11368-117I9	16.59	10.06
Synoviocyte, donor3	11440-118H9	13.18	12.29
Trabecular Meshwork Cells, donor1	11532-120A2	23.94	12.15
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	9.96	3.94
Tracheal Epithelial Cells, donor1	11292-117A5	9.75	10.61
Tracheal Epithelial Cells, donor2	11369-118A1	11.98	6.19
Tracheal Epithelial Cells, donor3	11441-118I1	8.59	8.59
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	19.81	13.41
Urethra, donor2	10319-105A4	8.99	23.38
Urothelial Cells, donor1	11520-119H8	9.56	14.35
Urothelial Cells, donor2	11600-120H7	5.21	7.61
Urothelial Cells, donor3	11681-122H7	5.96	7.33
Urothelial cells, donor0	11216-116B1	21.18	16.49
Whole blood (ribopure), donor090309, donation1	12179-129A1	8.90	35.59
Whole blood (ribopure), donor090309, donation2	12180-129A2	7.15	38.60
Whole blood (ribopure), donor090309, donation3	12181-129A3	3.42	15.06
Whole blood (ribopure), donor090325, donation1	12176-128I7	6.20	23.76
Whole blood (ribopure), donor090325, donation2	12177-128I8	5.81	18.01
Whole blood (ribopure), donor090612, donation1	12182-129A4	12.49	29.15
Whole blood (ribopure), donor090612, donation2	12183-129A5	7.34	31.20
Whole blood (ribopure), donor090612, donation3	12184-129A6	3.65	18.26
Wilms' tumor cell line:G-401	10809-111A8	22.21	5.92
Wilms' tumor cell line:HFWT	10597-108E3	11.44	13.20
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	15.64	8.38
achilles tendon, donor2	10292-104G4	14.47	14.47
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	23.71	21.93
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	11.84	30.65
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	18.04	27.30
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	11.97	76.46
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	38.79	10.68
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	43.57	37.01
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	12.52	22.05
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	22.47	36.57
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	21.23	35.53
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	26.02	49.70
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	7.73	37.72
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	15.60	7.80
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	38.81	14.18
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	5.44	35.47
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	9.35	27.18
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	4.65	22.31
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	7.81	14.39
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	13.20	48.81
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	15.79	37.12
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	16.68	41.55
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	17.57	41.40
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	12.25	31.85
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	14.34	11.01
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	13.01	5.57
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	14.69	13.56
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	29.22	13.96
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	33.74	37.49
adenocarcinoma cell line:IM95m	10796-110I4	9.66	17.19
adipose tissue, adult, pool1	10010-101C1	12.72	11.32
adipose, donor1	10184-103D4	49.84	8.80
adipose, donor2	10185-103D5	35.69	6.08
adipose, donor3	10186-103D6	43.02	9.53
adipose, donor4	10187-103D7	32.07	7.80
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	16.10	36.14
adrenal gland, adult, pool1	10081-102A9	3.64	18.19
adult T-cell leukemia cell line:ATN-1	10421-106C7	12.94	18.81
alveolar cell carcinoma cell line:SW 1573	10708-109H6	17.15	22.51
amniotic membrane cells, donor1	12235-129G3	4.17	12.98
amniotic membrane cells, donor2	12236-129G4	4.40	14.54
amniotic membrane cells, donor3	12237-129G5	2.65	13.55
amygdala - adult, donor10196	10167-103B5	3.56	39.13
amygdala, adult, donor10252	10151-102I7	8.92	37.31
amygdala, newborn, donor10223	10360-105E9	11.94	35.83
anaplastic carcinoma cell line:8305C	10428-106D5	4.58	4.71
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	18.97	37.06
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	36.41	7.68
aorta, adult, pool1	10052-101G7	10.98	12.75
appendix, adult	10189-103D9	8.15	20.96
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	34.74	14.79
artery, adult	10190-103E1	9.51	9.51
astrocytoma cell line:TM-31	10425-106D2	77.65	14.78
b cell line:RPMI1788	10427-106D4	19.33	21.12
basal cell carcinoma cell line:TE 354.T	10702-109G9	17.76	15.81
bile duct carcinoma cell line:HuCCT1	10432-106D9	13.99	15.68
bile duct carcinoma cell line:TFK-1	10496-107C1	4.35	8.70
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	6.71	29.08
bladder, adult, pool1	10011-101C2	10.76	17.93
blood, adult, pool1	10053-101G8	15.50	22.15
bone marrow stromal cell line:StromaNKtert	10686-109F2	10.28	18.84
bone marrow, adult	10192-103E3	45.21	37.79
brain, adult, donor1	10084-102B3	16.40	48.18
brain, adult, pool1	10012-101C3	6.57	38.20
brain, fetal, pool1	10085-102B4	10.69	85.48
breast carcinoma cell line:MCF7	10482-107A5	1.32	6.61
breast carcinoma cell line:MDA-MB-453	10419-106C5	4.12	7.36
breast, adult, donor1	10080-102A8	18.94	12.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	22.61	46.37
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	20.41	9.28
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	30.62	16.81
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	11.86	17.67
carcinoid cell line:NCI-H1770	10703-109H1	43.26	30.09
carcinoid cell line:NCI-H727	10735-110B6	15.20	31.94
carcinoid cell line:SK-PN-DW	10719-109I8	7.61	45.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	36.73	8.78
caudate nucleus - adult, donor10196	10177-103C6	6.91	50.66
caudate nucleus, adult, donor10252	10164-103B2	8.37	38.49
caudate nucleus, adult, donor10258	10379-105H1	4.58	52.73
caudate nucleus, newborn, donor10223	10354-105E3	16.11	34.06
cerebellum - adult, donor10196	10173-103C2	2.91	40.79
cerebellum, adult, donor10252	10166-103B4	9.18	36.51
cerebellum, adult, pool1	10083-102B2	13.11	36.22
cerebellum, newborn, donor10223	10357-105E6	16.61	23.25
cerebral meninges, adult	10188-103D8	7.31	49.42
cerebrospinal fluid, donor2	10294-104G6	6.58	14.62
cervical cancer cell line:D98-AH2	10552-107I3	8.91	7.19
cervical cancer cell line:ME-180	10553-107I4	5.30	11.60
cervix, adult, pool1	10013-101C4	14.91	18.79
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	30.10	16.16
chondrosarcoma cell line:SW 1353	10700-109G7	28.74	19.59
choriocarcinoma cell line:BeWo	10423-106C9	19.51	3.98
choriocarcinoma cell line:SCH	10785-110H2	32.28	4.31
choriocarcinoma cell line:T3M-3	10618-108G6	14.71	4.27
chorionic membrane cells, donor1	12238-129G6	9.69	12.54
chorionic membrane cells, donor2	12239-129G7	25.55	8.55
chorionic membrane cells, donor3	12240-129G8	12.09	8.79
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	3.03	29.28
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	34.19	24.40
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	31.47	15.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	10.02	8.22
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	10.64	7.01
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	12.62	5.90
chronic myelogenous leukemia cell line:K562	10454-106G4	13.25	4.71
chronic myelogenous leukemia cell line:KU812	10409-106B4	22.67	12.77
clear cell carcinoma cell line:JHOC-5	10638-108I8	49.15	19.89
clear cell carcinoma cell line:TEN	10636-108I6	22.04	28.98
colon carcinoma cell line:CACO-2	10513-107D9	26.72	5.49
colon carcinoma cell line:COLO-320	10420-106C6	35.35	11.40
colon, adult, donor1	10082-102B1	11.90	22.61
colon, adult, pool1	10014-101C5	16.22	17.63
colon, fetal, donor1	10070-101I7	11.74	19.78
common myeloid progenitor CMP, donor1	12130-128D6	9.17	77.92
common myeloid progenitor CMP, donor2	12134-128E1	25.04	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	21.25	22.95
cord blood derived cell line:COBL-a 24h infection	10453-106G3	16.30	17.21
cord blood derived cell line:COBL-a untreated	10449-106F8	18.75	18.05
corpus callosum, adult, pool1	10042-101F6	14.15	50.53
cruciate ligament, donor2	10295-104G7	12.97	9.73
diaphragm, fetal, donor1	10069-101I6	18.46	10.43
diencephalon, adult	10193-103E4	7.68	33.60
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	6.43	11.48
ductal cell carcinoma cell line:KLM-1	10438-106E6	8.98	13.85
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	26.48	10.35
ductus deferens, adult	10196-103E7	9.47	16.94
duodenum, fetal, donor1, tech_rep1	10071-101I8	20.16	36.01
duodenum, fetal, donor1, tech_rep2	10071-101I8	11.77	15.45
dura mater, adult, donor1	10041-101F5	16.43	15.11
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	15.99	9.55
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	24.07	17.77
embryonic pancreas cell line:1B2C6	10604-108F1	23.43	10.48
embryonic pancreas cell line:1C3D3	10605-108F2	16.95	16.35
embryonic pancreas cell line:1C3IKEI	10606-108F3	21.30	8.95
embryonic pancreas cell line:2C6	10603-108E9	18.39	13.13
endometrial carcinoma cell line:OMC-2	10497-107C2	33.52	9.05
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	22.29	10.51
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	14.31	8.68
epidermoid carcinoma cell line:A431	10426-106D3	9.23	14.01
epidermoid carcinoma cell line:Ca Ski	10431-106D8	12.87	15.18
epididymis, adult	10197-103E8	9.84	18.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	23.77	17.92
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	12.98	12.19
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	1.83	3.28
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	2.07	3.25
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	3.92	3.70
esophagus, adult, pool1	10015-101C6	7.22	11.25
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	10.77	9.27
eye - muscle inferior rectus, donor1	10272-104E2	7.24	16.90
eye - muscle lateral, donor2	10298-104H1	8.42	18.94
eye - muscle medial, donor2	10299-104H2	5.95	19.35
eye - muscle superior, donor2	10297-104G9	11.46	12.61
eye - vitreous humor, donor1	10268-104D7	4.37	21.86
eye, fetal, donor1	10054-101G9	12.71	22.12
fibrosarcoma cell line:HT-1080	10758-110E2	22.44	10.90
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	26.59	11.87
frontal lobe, adult, pool1	10040-101F4	9.19	52.45
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	13.21	22.82
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	34.38	27.52
gall bladder, adult	10198-103E9	7.73	14.24
gamma delta positive T cells, donor1	11937-126A2	4.29	33.82
gamma delta positive T cells, donor2	11938-126A3	6.72	28.01
gastric adenocarcinoma cell line:MKN1	10614-108G2	10.56	5.91
gastric adenocarcinoma cell line:MKN45	10612-108F9	6.77	23.02
gastric cancer cell line:AZ521	10549-107H9	20.99	10.66
gastric cancer cell line:GSS	10560-108A2	43.93	13.73
gastrointestinal carcinoma cell line:ECC12	10615-108G3	35.87	23.07
giant cell carcinoma cell line:LU65	10487-107B1	9.29	5.05
giant cell carcinoma cell line:Lu99B	10433-106E1	32.19	8.68
glassy cell carcinoma cell line:HOKUG	10688-109F4	5.24	6.48
glioblastoma cell line:A172, tech_rep1	10444-106F3	24.70	11.51
glioblastoma cell line:A172, tech_rep2	10444-106F3	29.21	11.66
glioblastoma cell line:T98G	10485-107A8	39.51	16.00
glioma cell line:GI-1	10413-106B8	31.63	10.84
globus pallidus - adult, donor10196	10175-103C4	9.48	59.77
globus pallidus, adult, donor10252	10161-103A8	12.20	42.96
globus pallidus, adult, donor10258	10367-105F7	6.85	34.23
globus pallidus, newborn, donor10223	10364-105F4	13.32	24.51
granulocyte macrophage progenitor, donor1	12131-128D7	9.79	56.28
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	65.57
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	20.91
granulosa cell tumor cell line:KGN	10624-108H3	38.08	11.52
hIPS +CCl2, biol_rep1	14383-156B9	19.28	5.51
hIPS +CCl2, biol_rep2	14384-156C1	16.92	6.40
hIPS +CCl2, biol_rep3	14385-156C2	14.17	7.73
hIPS, biol_rep1	14380-156B6	4.31	4.31
hIPS, biol_rep2	14381-156B7	6.17	5.49
hIPS, biol_rep3	14382-156B8	1.10	70.62
hairy cell leukemia cell line:Mo	10712-109I1	7.18	14.08
heart - mitral valve, adult	10205-103F7	13.75	13.15
heart - pulmonic valve, adult	10206-103F8	11.24	12.03
heart - tricuspid valve, adult	10207-103F9	10.82	16.65
heart, adult, diseased post-infarction, donor1	10050-101G5	8.16	11.84
heart, adult, diseased, donor1	10051-101G6	12.35	8.52
heart, adult, pool1	10016-101C7	10.35	23.92
heart, fetal, pool1	10046-101G1	24.23	17.15
hepatic mesenchymal tumor cell line:LI90	10778-110G4	25.61	20.05
hepatoblastoma cell line:HuH-6	10633-108I3	8.32	4.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	19.89	6.41
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	22.45	8.01
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	21.32	6.67
hepatoma cell line:Li-7	10484-107A7	19.91	4.23
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	46.33	15.78
hippocampus - adult, donor10196	10169-103B7	8.52	45.42
hippocampus, adult, donor10252	10153-102I9	12.04	33.06
hippocampus, adult, donor10258	10374-105G5	1.49	43.32
hippocampus, newborn, donor10223	10363-105F3	10.22	32.08
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	31.74	8.54
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	24.54	5.69
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	30.47	5.59
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	32.70	7.33
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	37.96	4.91
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	34.92	5.31
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	44.96	8.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	41.36	10.13
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	38.37	6.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	51.62	10.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	51.27	10.77
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	46.46	12.79
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	25.51	4.85
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	14.74	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	23.56	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	43.15	5.92
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	45.79	4.80
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	37.98	7.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	36.36	6.78
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	43.20	10.46
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	37.28	9.71
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	34.95	7.84
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	48.77	9.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	50.22	9.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	31.96	6.47
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	33.66	7.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	47.77	6.94
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	44.36	5.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	43.08	5.38
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	43.88	3.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	36.20	5.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	40.51	9.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	37.97	6.16
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	50.11	9.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	37.10	12.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	49.74	6.05
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	28.50	6.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	32.09	4.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	32.20	4.88
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	33.62	4.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	104.10	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	49.64	3.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	42.14	4.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	34.74	7.60
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	35.23	7.47
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	31.03	4.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	65.14	10.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	50.11	7.27
immature langerhans cells, donor1	11904-125F5	21.79	25.18
immature langerhans cells, donor2	11905-125F6	7.92	27.72
insula, adult, pool1	10039-101F3	9.75	54.98
keratoacanthoma cell line:HKA-1	10791-110H8	3.58	19.83
kidney, adult, pool1	10017-101C8	23.53	17.62
kidney, fetal, pool1	10045-101F9	22.92	17.90
large cell lung carcinoma cell line:IA-LM	10509-107D5	33.94	6.82
large cell lung carcinoma cell line:NCI-H460	10839-111E2	22.12	9.40
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	22.20	9.36
left atrium, adult, donor1	10079-102A7	13.62	14.71
left ventricle, adult, donor1	10078-102A6	16.18	12.14
leiomyoblastoma cell line:G-402	10721-110A1	16.69	8.48
leiomyoma cell line:10964C	10569-108B2	11.50	4.67
leiomyoma cell line:15242A	10570-108B3	24.46	7.07
leiomyoma cell line:15425	10571-108B4	15.54	3.64
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	12.70
lens epithelial cell line:SRA 01/04	10647-109A8	17.77	11.50
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	47.22	9.92
liposarcoma cell line:KMLS-1	10782-110G8	23.28	15.62
liposarcoma cell line:SW 872	10726-110A6	38.99	18.28
liver, adult, pool1	10018-101C9	8.10	5.67
liver, fetal, pool1	10086-102B5	11.29	7.53
locus coeruleus - adult, donor10196	10182-103D2	14.73	38.94
locus coeruleus, adult, donor10252	10165-103B3	11.26	49.09
locus coeruleus, adult, donor10258	10375-105G6	16.36	73.92
locus coeruleus, newborn, donor10223	10362-105F2	16.82	17.67
lung adenocarcinoma cell line:A549	10499-107C4	21.04	12.04
lung adenocarcinoma cell line:PC-14	10408-106B3	15.86	23.44
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	14.50	12.92
lung, adult, pool1	10019-101D1	25.87	18.55
lung, fetal, donor1	10068-101I5	37.96	36.82
lung, right lower lobe, adult, donor1	10075-102A3	26.12	15.58
lymph node, adult, donor1	10077-102A5	16.57	8.99
lymphangiectasia cell line:DS-1	10727-110A7	15.78	12.27
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	11.62	19.92
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	4.25	11.89
mature adipocyte, donor1	12231-129F8	4.44	9.77
mature adipocyte, donor2	12232-129F9	6.64	15.36
mature adipocyte, donor3	12233-129G1	9.48	8.53
mature adipocyte, donor4	12234-129G2	8.69	10.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	7.39	25.49
medial frontal gyrus - adult, donor10196	10170-103B8	2.26	67.68
medial frontal gyrus, adult, donor10252	10150-102I6	5.89	28.32
medial frontal gyrus, adult, donor10258	10368-105F8	4.13	58.77
medial frontal gyrus, newborn, donor10223	10352-105E1	11.09	34.55
medial temporal gyrus - adult, donor10196	10183-103D3	7.76	45.56
medial temporal gyrus, adult, donor10252	10156-103A3	5.73	35.44
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	0.00	32.75
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	57.41
medial temporal gyrus, newborn, donor10223	10353-105E2	5.03	54.92
medulla oblongata - adult, donor10196	10174-103C3	16.87	32.45
medulla oblongata, adult, donor10252	10155-103A2	13.78	31.89
medulla oblongata, adult, pool1	10038-101F2	16.08	45.63
medulla oblongata, newborn, donor10223	10361-105F1	20.14	22.22
medulloblastoma cell line:D283 Med	10838-111E1	9.52	5.09
medulloblastoma cell line:ONS-76	10759-110E3	20.05	9.54
melanoma cell line:COLO 679	10514-107E1	28.17	8.91
melanoma cell line:G-361	10465-106H6	37.19	8.42
meningioma cell line:HKBMM	10691-109F7	8.50	9.59
merkel cell carcinoma cell line:MKL-1	10843-111E6	14.98	21.15
merkel cell carcinoma cell line:MS-1	10844-111E7	18.15	29.81
mesenchymal precursor cell - adipose, donor1	11747-123G1	26.85	10.13
mesenchymal precursor cell - adipose, donor2	11748-123G2	23.09	6.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	19.88	5.38
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	37.37	9.97
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	35.05	10.59
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	18.74	10.41
mesenchymal precursor cell - cardiac, donor1	11752-123G6	29.35	5.49
mesenchymal precursor cell - cardiac, donor2	11753-123G7	23.12	7.94
mesenchymal precursor cell - cardiac, donor3	11754-123G8	29.05	5.97
mesenchymal precursor cell - cardiac, donor4	11755-123G9	37.95	8.24
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	34.85	7.82
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	24.70	10.21
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	39.30	8.44
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	32.12	3.84
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	31.85	13.88
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	22.29	10.42
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	33.21	10.24
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	28.50	7.07
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	45.31	11.33
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	26.00	9.12
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	48.40	7.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	27.98	11.41
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	23.46	9.16
mesenchymal stem cell line:Hu5/E18	10568-108B1	33.68	9.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	6.85	9.59
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	7.67	7.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	9.16	7.33
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	7.39	6.16
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	8.00	5.88
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	9.82	7.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	6.29	6.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	8.34	6.49
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	9.52	8.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	10.04	7.81
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	8.65	6.25
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	11.00	8.07
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	7.38	5.71
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	11.87	4.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	6.87	6.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	0.00	8.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	9.09	9.42
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	5.82	5.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	12.79	8.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	8.18	8.18
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	9.72	5.44
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	10.49
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	5.96	5.96
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	10.67	5.93
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	3.66	6.09
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	54.10
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	6.33	5.07
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	11.73	7.93
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	6.45	10.75
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	11.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	7.33	2.85
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.15	3.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	6.48	8.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	7.48	5.92
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	8.02	12.03
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	9.46	3.55
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	10.27
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	8.95	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	14.35	10.89
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	12.34	7.85
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	11.45	10.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	8.06	9.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	4.36	10.90
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	8.87	11.40
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	4.86	6.68
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	11.53	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	8.73	10.12
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	6.17	5.52
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	13.24	9.17
mesodermal tumor cell line:HIRS-BM	10696-109G3	10.83	8.51
mesothelioma cell line:ACC-MESO-1	10493-107B7	21.26	20.55
mesothelioma cell line:ACC-MESO-4	10494-107B8	20.85	5.56
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	8.55
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	20.45	8.73
mesothelioma cell line:Mero-25	10850-111F4	8.85	3.18
mesothelioma cell line:Mero-41	10851-111F5	27.63	11.00
mesothelioma cell line:Mero-48a	10852-111F6	20.15	12.18
mesothelioma cell line:Mero-82	10853-111F7	24.18	8.67
mesothelioma cell line:Mero-83	10854-111F8	10.21	5.45
mesothelioma cell line:Mero-84	10855-111F9	9.61	6.32
mesothelioma cell line:Mero-95	10856-111G1	24.02	6.21
mesothelioma cell line:NCI-H2052	10847-111F1	13.75	3.15
mesothelioma cell line:NCI-H226	10846-111E9	27.15	9.23
mesothelioma cell line:NCI-H2452	10848-111F2	19.82	8.20
mesothelioma cell line:NCI-H28	10845-111E8	32.32	15.01
mesothelioma cell line:No36	10857-111G2	15.01	11.09
mesothelioma cell line:ONE58	10858-111G3	26.01	12.19
migratory langerhans cells, donor1	11901-125F2	2.69	3.45
migratory langerhans cells, donor2	11902-125F3	5.74	7.08
migratory langerhans cells, donor3	11903-125F4	3.77	8.97
mixed mullerian tumor cell line:HTMMT	10689-109F5	22.20	9.14
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	33.27	6.78
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	3.23	5.99
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	18.65	14.27
myelodysplastic syndrome cell line:SKM-1	10772-110F7	10.35	51.00
myeloma cell line:PCM6	10474-106I6	34.20	43.88
myxofibrosarcoma cell line:MFH-ino	10600-108E6	18.77	8.62
myxofibrosarcoma cell line:NMFH-1	10684-109E9	23.54	10.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	6.57	9.25
nasal epithelial cells, donor1, tech_rep2	12226-129F3	6.03	10.00
nasal epithelial cells, donor2	12227-129F4	7.18	8.83
neuroblastoma cell line:CHP-134	10508-107D4	27.61	47.39
neuroblastoma cell line:NB-1	10539-107G8	49.20	15.72
neuroblastoma cell line:NBsusSR	10607-108F4	11.60	30.58
neuroblastoma cell line:NH-12	10555-107I6	17.52	17.14
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	3.32	28.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	3.80	23.92
neuroectodermal tumor cell line:TASK1	10774-110F9	17.31	34.62
neuroepithelioma cell line:SK-N-MC	10728-110A8	0.64	68.66
neurofibroma cell line:Hs 53.T	10729-110A9	22.36	9.32
neutrophil PMN, donor1	12133-128D9	0.00	44.62
neutrophil PMN, donor2	12137-128E4	13.28	13.28
neutrophil PMN, donor3	12141-128E8	0.00	28.41
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	59.02	15.39
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	36.82	68.84
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	21.16	9.62
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	24.96	11.56
nucleus accumbens, adult, pool1	10037-101F1	8.81	55.02
occipital cortex - adult, donor10196	10172-103C1	4.12	57.69
occipital cortex, adult, donor10252	10163-103B1	5.64	38.11
occipital cortex, newborn, donor10223	10355-105E4	7.28	33.85
occipital lobe, adult, donor1	10076-102A4	11.55	70.32
occipital lobe, fetal, donor1	10073-102A1	34.33	97.41
occipital pole, adult, pool1	10036-101E9	7.02	38.87
olfactory region, adult	10195-103E6	7.07	34.20
optic nerve, donor1	10277-104E7	12.01	60.03
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	14.01	10.37
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	14.01	5.50
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	4.57	12.19
oral squamous cell carcinoma cell line:SAS	10544-107H4	19.87	11.32
osteoclastoma cell line:Hs 706.T	10704-109H2	15.58	15.87
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	32.70	47.65
osteosarcoma cell line:HS-Os-1	10558-107I9	7.85	11.45
ovary, adult, pool1	10020-101D2	14.85	12.84
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	13.20	33.91
pancreas, adult, donor1	10049-101G4	9.41	11.29
pancreatic carcinoma cell line:NOR-P1	10698-109G5	21.52	3.63
papillary adenocarcinoma cell line:8505C	10437-106E5	20.10	9.54
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	21.53	9.27
paracentral gyrus, adult, pool1	10035-101E8	8.33	51.89
parietal cortex, adult, donor10258	10373-105G4	1.47	44.04
parietal lobe - adult, donor10196	10171-103B9	9.40	45.14
parietal lobe, adult, donor10252	10157-103A4	6.56	25.94
parietal lobe, adult, pool1	10034-101E7	8.81	51.64
parietal lobe, fetal, donor1	10072-101I9	24.25	94.07
parietal lobe, newborn, donor10223	10356-105E5	10.47	37.76
parotid gland, adult	10199-103F1	7.40	8.63
penis, adult	10200-103F2	6.45	12.89
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	1.49	41.09
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	25.35	25.35
pineal gland - adult, donor10196	10179-103C8	9.03	26.45
pineal gland, adult, donor10252	10160-103A7	10.07	45.60
pineal gland, adult, donor10258	10377-105G8	6.90	28.22
pituitary gland - adult, donor10196	10180-103C9	14.17	53.63
pituitary gland, adult, donor10252	10162-103A9	21.37	60.46
pituitary gland, adult, donor10258	10378-105G9	13.62	38.31
placenta, adult, pool1	10021-101D3	18.60	11.50
plasma cell leukemia cell line:ARH-77	10840-111E3	17.61	24.50
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	16.65	12.76
pons, adult, pool1	10033-101E6	12.22	54.57
postcentral gyrus, adult, pool1	10032-101E5	6.80	44.98
promyelocytes/myelocytes PMC, donor1	12132-128D8	14.64	56.47
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	27.54
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	23.47
prostate cancer cell line:DU145	10490-107B4	38.75	12.53
prostate cancer cell line:PC-3	10439-106E7	24.50	13.61
prostate, adult, pool1	10022-101D4	15.69	17.14
putamen, adult, donor10196	10176-103C5	9.91	47.92
putamen, adult, donor10252	10152-102I8	0.00	52.94
putamen, adult, donor10258, tech_rep1	10372-105G3	6.56	29.51
putamen, adult, donor10258, tech_rep2	10372-105G3	3.38	45.42
putamen, newborn, donor10223	10365-105F5	24.74	19.49
rectal cancer cell line:TT1TKB	10469-106I1	19.49	28.80
rectum, fetal, donor1	10067-101I4	43.12	15.30
renal cell carcinoma cell line:OS-RC-2	10411-106B6	30.32	21.41
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	62.55	28.58
retina, adult, pool1	10030-101E3	17.30	26.04
retinoblastoma cell line:Y79	10475-106I7	19.49	22.34
rhabdomyosarcoma cell line:KYM-1	10787-110H4	12.79	13.40
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	21.93	16.31
sacrococcigeal teratoma cell line:HTST	10695-109G2	12.88	16.67
salivary acinar cells, donor1	11771-123I7	4.86	4.53
salivary acinar cells, donor2	11772-123I8	3.86	5.92
salivary acinar cells, donor3	11773-123I9	0.66	9.27
salivary gland, adult, pool1	10093-102C3	6.86	16.59
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	47.13	11.63
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	51.14	11.99
seminal vesicle, adult	10201-103F3	11.11	15.87
serous adenocarcinoma cell line:JHOS-2	10639-108I9	14.58	13.12
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	12.58	10.32
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	14.05	10.04
serous cystadenocarcinoma cell line:HTOA	10693-109F9	14.37	7.52
signet ring carcinoma cell line:Kato III	10436-106E4	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	9.55	18.71
skeletal muscle - soleus muscle, donor1	10282-104F3	5.67	8.51
skeletal muscle, adult, pool1	10023-101D5	6.60	7.80
skeletal muscle, fetal, donor1	10066-101I3	14.07	6.03
skin, adult, donor1	10074-102A2	6.79	20.36
skin, fetal, donor1	10065-101I2	18.94	15.15
small cell cervical cancer cell line:HCSC-1	10800-110I8	50.70	18.68
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	25.22	12.29
small cell lung carcinoma cell line:DMS 144	10841-111E4	51.27	27.95
small cell lung carcinoma cell line:LK-2	10541-107H1	23.24	18.79
small cell lung carcinoma cell line:NCI-H82	10842-111E5	30.40	20.11
small cell lung carcinoma cell line:WA-hT	10562-108A4	37.05	17.22
small intestine, adult, pool1	10024-101D6	18.16	14.45
small intestine, fetal, donor1	10064-101I1	13.27	17.69
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	7.69	41.03
smooth muscle, adult, pool1	10048-101G3	9.05	18.35
somatostatinoma cell line:QGP-1	10781-110G7	15.55	35.11
spinal cord - adult, donor10196	10181-103D1	20.88	43.13
spinal cord, adult, donor10252	10159-103A6	14.59	42.98
spinal cord, adult, donor10258	10369-105F9	4.15	35.97
spinal cord, fetal, donor1	10056-101H2	39.03	49.40
spinal cord, newborn, donor10223	10359-105E8	15.15	20.21
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	23.75	12.55
spleen, adult, pool1	10025-101D7	18.39	11.89
spleen, fetal, pool1	10044-101F8	16.13	14.86
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	24.43	12.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	14.43	14.05
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	6.64	17.82
squamous cell carcinoma cell line:T3M-5	10616-108G4	8.21	15.64
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	28.93	36.36
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	9.74	15.67
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	47.81	14.81
stomach, fetal, donor1	10062-101H8	14.95	29.90
submaxillary gland, adult	10202-103F4	9.11	15.38
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27
substantia nigra, adult, donor10252	10158-103A5	11.01	39.88
substantia nigra, adult, donor10258	10371-105G2	2.59	55.86
substantia nigra, newborn, donor10223	10358-105E7	13.42	26.85
synovial sarcoma cell line:HS-SY-II	10441-106E9	18.11	29.58
temporal lobe, adult, pool1	10031-101E4	6.53	43.57
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	29.92	133.19
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	11.43	69.45
tenocyte, donor1	11763-123H8	16.76	9.43
tenocyte, donor2	11765-123I1	14.12	16.40
tenocyte, donor3	11768-123I4	10.01	11.12
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	49.46	9.35
teratocarcinoma cell line:NCR-G1	10798-110I6	29.90	5.24
teratocarcinoma cell line:PA-1	10807-111A6	51.45	13.48
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	31.99	10.03
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	19.66	15.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	34.03	6.87
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	10.75	4.23
testis, adult, pool1	10026-101D8	22.12	19.00
testis, adult, pool2	10096-102C6	30.67	27.97
thalamus - adult, donor10196	10168-103B6	11.04	57.41
thalamus, adult, donor10252	10154-103A1	9.69	32.66
thalamus, adult, donor10258, tech_rep1	10370-105G1	3.08	52.35
thalamus, adult, donor10258, tech_rep2	10370-105G1	9.22	43.64
thalamus, newborn, donor10223	10366-105F6	16.11	16.68
throat, adult	10209-103G2	9.74	12.98
throat, fetal, donor1	10061-101H7	17.06	18.28
thymic carcinoma cell line:Ty-82	10803-111A2	10.33	26.83
thymus, adult, pool1	10027-101D9	3.28	26.64
thymus, fetal, pool1	10043-101F7	7.59	31.48
thyroid carcinoma cell line:KHM-5M	10776-110G2	22.74	13.16
thyroid carcinoma cell line:TCO-1	10783-110G9	14.53	10.06
thyroid, adult, pool1	10028-101E1	20.16	25.66
thyroid, fetal, donor1	10060-101H6	15.29	17.93
tongue epidermis (fungiform papillae), donor1	10288-104F9	3.08	6.16
tongue, adult	10203-103F5	3.95	7.44
tongue, fetal, donor1	10059-101H5	19.70	6.70
tonsil, adult, pool1	10047-101G2	6.11	16.03
trachea, adult, pool1	10029-101E2	9.73	13.01
trachea, fetal, donor1	10058-101H4	12.69	15.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	23.74	6.73
transitional-cell carcinoma cell line:5637	10418-106C4	21.48	17.93
transitional-cell carcinoma cell line:JMSU1	10492-107B6	13.32	7.99
tridermal teratoma cell line:HGRT	10694-109G1	26.64	15.22
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	13.71	7.36
umbilical cord, fetal, donor1	10057-101H3	10.43	6.26
uterus, adult, pool1	10100-102D1	22.69	19.79
uterus, fetal, donor1	10055-101H1	38.91	24.06
vagina, adult	10204-103F6	14.22	14.86
vein, adult	10191-103E2	8.99	13.81
xeroderma pigentosum b cell line:XPL 17	10563-108A5	14.42	20.29